Hormonal
Consumption of flavonoid-rich foods (cocoa, tea, berries) produces small but measurable improvements in blood pressure, endothelial function, and insulin resistance, mediated by enhanced nitric oxide bioavailability and AMPK activation.
Incorporate flavonoid-rich foods like dark chocolate (cocoa), tea, and berries into your daily diet. You do not need large quantities; even small amounts (e.g., ~30 kcal/d of dark chocolate) can contribute to lower blood pressure and better vascular health. Focus on consistency rather than high doses of supplements.
Flavonoid-rich cocoa produces small but measurable benefits on blood pressure (BP), endothelial function, insulin resistance, and blood lipids... These benefits seem related to improved endothelial production of NO, a fundamental pathway for vascular and metabolic health.
Why this rating
Supported by systematic reviews and meta-analyses of randomized controlled trials (RCTs), though some trials had limited duration or bias.
Source
Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health
Dariush Mozaffarian et al. · Circulation Research · 2018
DOI 10.1161/circresaha.117.309008
More from this paper
- Dairy consumption has complex cardiometabolic effects that differ from isolated nutrient recommendations, with specific components like dairy fats and proteins offering potential benefits that contradict traditional low-fat dairy guidelines.Moderate
- Short-chain fatty acids (SCFA) produced by gut microbiota from flavonoid and fiber fermentation influence energy metabolism, glucose-insulin homeostasis, and inflammatory pathways, with effects mediated by G-protein-coupled receptors (GPR).Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →